drugset / Trial / NCT00240721

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

NCT00240721

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study is to evaluate the effectiveness and safety of topiramate compared with placebo in the treatment of acute manic or mixed episodes in patients with Bipolar I Disorder.

Timeline

Start
2000-10
Primary completion
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 400 mg
Subject Topiramate Small molecule 600 mg

Indications